Prostate Cancer Treatment Fort Myers FL
When it comes to prostate cancer treatment, the opinions of multiple physicians are better than one. That’s why Moffitt Cancer Center takes a multispecialty approach to treatment for our patients from Fort Myers, Florida, and throughout the country. Located in nearby Tampa, Moffitt is a global leader in the treatment of urologic cancers.
What does prostate cancer treatment involve?
There are several factors that may influence a man’s ideal course of treatment, such as his age, medical history and the stage of his prostate cancer. Generally speaking, treatment may involve surgery to remove tumors, chemotherapy, hormone therapy and radiation therapy to destroy cancer cells and targeted biological therapies and radiopharmaceuticals to impede cancer growth. There is also the option of clinical trials if applicable.
Prostate cancer treatment at Moffitt is far from one-size-fits-all. The specialists within our Urologic Oncology Program focus exclusively on urologic cancers and collaborate as a tumor board to develop individualized treatment plans for our patients. These specialists include:
- Medical oncologists
- Radiation oncologists
- Surgeons
- Interventional radiologists
- And other experts
How to become a Moffitt patient
Moffitt invites patients who are traveling from Fort Myers, FL, to take advantage of reduced rates at our partner hotels. These establishments are located near our cancer center and are in compliance with our rigorous hygiene standards.
Medically reviewed by Monica Chatwal, MD.
Men from Fort Myers, FL, who would could like to consult a Moffitt physician regarding their prostate cancer treatment options are encouraged to call 1-888-663-3488 or complete a new patient registration form online. A referral is not required to visit Moffitt.
Prostate Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer